Lupin Atlantis Holdings SA

3 trials 3 recruiting Commercial sponsor Merged from 2 name variants

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

3 Recruiting

0 Completed trials

6 Countries active

2 Unique IMPs

N/A Results reported

Phase III

Top indications

Myotonic dystrophy 3

Top IMPs

MEXILETINE HYDROCHLORIDE 3 MEXILETINE 1

All trials

3 total

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients with Myotonic Dystrophy … Recruiting

2024-511178-66-00 Phase III 5 countries MEXILETINE HYDROCHLORIDE
An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR compared to Mexiletine IR in Patients wi… Recruiting

2024-514970-27-00 Phase III 4 countries MEXILETINE; MEXILETINE HYDROCHLORIDE
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Investigate the Efficacy and Safety of Once Daily Mexiletine PR During… Recruiting

2024-511179-13-00 Phase III 5 countries MEXILETINE HYDROCHLORIDE

Showing 1–3 of 3 trials

← All sponsors A–Z